Sara Linse

Active 1987–2025

166
Papers
29,985
Citations
87
h-index
158
i10-index

Citations

Citations per year for Sara Linse1971: 1 citations1988: 3 citations1989: 10 citations1990: 14 citations1991: 14 citations1992: 13 citations1993: 11 citations1994: 17 citations1995: 27 citations1996: 11 citations1997: 14 citations1998: 16 citations1999: 13 citations2000: 21 citations2001: 16 citations2002: 32 citations2003: 39 citations2004: 33 citations2005: 42 citations2006: 46 citations2007: 66 citations2008: 117 citations2009: 122 citations2010: 155 citations2011: 219 citations2012: 204 citations2013: 246 citations2014: 284 citations2015: 304 citations2016: 346 citations2017: 427 citations2018: 449 citations2019: 1,195 citations2020: 1,436 citations2021: 1,248 citations2022: 995 citations2023: 797 citations2024: 1,183 citations2025: 668 citations2026: 12 citations1972–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,883 citing papers, 19.9% of this breakdownChina: 1,040 citing papers, 11% of this breakdownUnited Kingdom: 817 citing papers, 8.6% of this breakdownGermany: 577 citing papers, 6.1% of this breakdownSweden: 495 citing papers, 5.2% of this breakdownItaly: 407 citing papers, 4.3% of this breakdownIndia: 374 citing papers, 4% of this breakdownFrance: 301 citing papers, 3.2% of this breakdownSpain: 243 citing papers, 2.6% of this breakdownAustralia: 241 citing papers, 2.5% of this breakdownCanada: 240 citing papers, 2.5% of this breakdownSwitzerland: 237 citing papers, 2.5% of this breakdown
0%19.9%Other 27.6%

Fields

  • Medicine36.8%
  • Biochemistry, Genetics and Molecular Biology26%
  • Materials Science16.4%
  • Environmental Science4.6%
  • Neuroscience4.1%
  • Chemistry2.6%
  • Other9.5%

Topics

  • Alzheimer's disease research and treatments11.3%
  • Protein Structure and Dynamics4.9%
  • Nanoparticle-Based Drug Delivery3.9%
  • Computational Drug Discovery Methods3.1%
  • Parkinson's Disease Mechanisms and Treatments2.7%
  • Supramolecular Self-Assembly in Materials2.5%
  • Other71.6%

Coauthors

All papers

Open in search
  1. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 3,172

  2. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 1,447

  3. Molecular mechanisms of protein aggregation from global fitting of kinetic models

    Authors: , , , , , , , - Nature Protocols 2016 cited by 789

  4. On the lag phase in amyloid fibril formation

    Authors: , , - Physical Chemistry Chemical Physics 2015 cited by 774

  5. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 687

  6. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2019 cited by 370

  7. Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide

    Authors: , , , , , , , , , , , - Nature Chemistry 2020 cited by 343

  8. Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies

    Authors: , , , , , , , , , , , , , , , , - Nature Structural & Molecular Biology 2020 cited by 197

  9. Secondary nucleation in amyloid formation

    Authors: , , , , , , , - Chemical Communications 2018 cited by 482

  10. Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils

    Authors: , , , , , , , , , , - Journal of the American Chemical Society 2016 cited by 824

  11. Amyloid formation as a protein phase transition

    Authors: , , , , , - Nature Reviews Physics 2023 cited by 164

  12. Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 513

  13. Acceleration of α-Synuclein Aggregation by Exosomes

    Authors: , , , , , , - Journal of Biological Chemistry 2014 cited by 377

  14. Methods for the detection and analysis of protein–protein interactions

    Authors: , , - PROTEOMICS 2007 cited by 713

  15. A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers

    Authors: , , , , , , , , , , , , , , - Nature Structural & Molecular Biology 2015 cited by 424

  16. Secondary nucleation of monomers on fibril surface dominatesα-synuclein aggregation and provides autocatalytic amyloid amplification

    Authors: , , , , , , , - Quarterly Reviews of Biophysics 2017 cited by 262

  17. Kinetic diversity of amyloid oligomers

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 186

  18. Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes

    Authors: , , , , , , , , , , , , , - Nature Chemistry 2018 cited by 255

  19. Identification of on- and off-pathway oligomers in amyloid fibril formation

    Authors: , , , , , , - Chemical Science 2020 cited by 122

  20. Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation

    Authors: , , , , , , , , , - Nature Communications 2016 cited by 266

  21. Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates

    Authors: , , , , , , , , , , , - Science Advances 2019 cited by 162

  22. Uncovering the universality of self-replication in protein aggregation and its link to disease

    Authors: , , , , , , , , , , - Science Advances 2022 cited by 59

  23. The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 100

  24. Amyloid β-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process

    Authors: , , , - ACS Chemical Neuroscience 2009 cited by 391